Signal active
Organization
Contact Information
Overview
At Cradle Genomics, their mission is to provide knowledge that helps every pregnancy. They're dedicated to the transformation of non-invasive prenatal testing (NIPT) by offering the most comprehensive fetal genetic analysis and pregnancy health screening solutions at the earliest stages of pregnancy. Cradle Genomics is newly formed with their headquarters based in San Diego and additional R&D operations located in Detroit. Cradle tests are based on the genetic analysis of fetal cells that are quickly collected during a first trimester visit with no risk to the mother or developing fetus.
About
Biotechnology
2018
1-10
Headquarters locations
San Diego, California, United States, North America
Social
Profile Resume
Cradle Genomics headquartered in United States, North America, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $184.8M in funding across 8 round(s). With a team of 1-10 employees, Cradle Genomics is actively contributing to advancements in Biotechnology. Their latest funding round, Corporate Round - Cradle Genomics, raised $6.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
2
1
0
$23.1M
Details
1
Cradle Genomics has raised a total of $23.1M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2019 | Early Stage Venture | 17.1M |
Investors
Cradle Genomics is funded by 9 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Cradle Genomics | - | FUNDING ROUND - Cradle Genomics | 17.1M |
Illumina Ventures | - | FUNDING ROUND - Illumina Ventures | 17.1M |
Cradle Genomics | - | FUNDING ROUND - Cradle Genomics | 6.0M |
Pacific West Bank | - | FUNDING ROUND - Pacific West Bank | 6.0M |